Evidence map›Paper›PMID 41264036›Full record

ArticleActa parasitologica2025

Cutaneous Leishmaniasis in Southeastern Algeria: Clinical, Parasitological Diagnosis and Molecular Identification.

Boutheyna Boulal, Latifa Remadi, Linda Grigoraki, John Vontas, Djamel Bendjoudi

Abstract read
PubMed Publisher
In one paragraph

Article in Acta parasitologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Boutheyna BoulalLaboratory of Biotechnology, Environment and Health, Faculty of Nature and Life Sciences, University of Blida 1, Blida, 09000, Algeria. boutheynaboulal04@gmail.com.
Latifa RemadiInstitute of Molecular Biology & Biotechnology, Foundation for Research & Technology Hellas, Heraklion, 70013, Greece.
Linda GrigorakiInstitute of Molecular Biology & Biotechnology, Foundation for Research & Technology Hellas, Heraklion, 70013, Greece.
John VontasInstitute of Molecular Biology & Biotechnology, Foundation for Research & Technology Hellas, Heraklion, 70013, Greece.
Djamel BendjoudiLaboratory of Biotechnology, Environment and Health, Faculty of Nature and Life Sciences, University of Blida 1, Blida, 09000, Algeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeCutaneous leishmaniasis (CL) is an endemic disease in Algeria. In southeastern regions, data concerning this infection are limited. Therefore, we aimed to assess the epidemiological status and identify the causative Leishmania spp. in El Meghaier province.

methodsA retrospective study was conducted between 2023 and 2024. Diagnosis was confirmed by microscopic examination. For patients with positive results, clinical and demographic data were recorded. Molecular analysis was then carried out on DNA extracted from Giemsa-stained slides to identify the Leishmania species.

resultsIn total 722 suspected cases were analyzed and only 118 were positive cases. A predominance in males was detected, and the most affected group age was [≥ 20] years old (N = 51; 43.2%). The statistical analysis showed strong association between age group and the positivity rate (X

conclusionThese findings confirm, for the first time, the occurrence of both L. major and L. infantum in the study area. Further studies are needed to investigate the potential vectors and reservoirs involved.

Indexed as

LeishmaniaLeishmaniasis, CutaneousAdolescentAdultAgedAged, 80 and overAlgeriaChildChild, PreschoolDNA, ProtozoanFemaleHumansInfantMaleMiddle AgedPolymerase Chain ReactionDNA, ProtozoanAlgeriaCutaneous leishmaniasisEl meghaierLeishmaniaMicroscopic examinationPCR

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.